JW Lifescience Corporation (KRX:234080)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,400
-100 (-0.87%)
At close: Mar 25, 2025, 3:30 PM KST

JW Lifescience Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
222,478206,860188,931169,817183,521
Upgrade
Other Revenue
---0-0-
Upgrade
Revenue
222,478206,860188,931169,817183,521
Upgrade
Revenue Growth (YoY)
7.55%9.49%11.26%-7.47%7.81%
Upgrade
Cost of Revenue
165,010154,507140,972120,788124,243
Upgrade
Gross Profit
57,46852,35347,95949,02959,278
Upgrade
Selling, General & Admin
16,51815,10013,35812,90813,180
Upgrade
Research & Development
4,0305,1615,7376,2425,195
Upgrade
Other Operating Expenses
262.41161.56159.04162.39199.85
Upgrade
Operating Expenses
21,61021,49120,87020,61219,827
Upgrade
Operating Income
35,85830,86227,08928,41739,451
Upgrade
Interest Expense
-2,061-2,693-3,092-1,281-2,609
Upgrade
Interest & Investment Income
1,5061,1301,087130.361,427
Upgrade
Earnings From Equity Investments
10,3926,489-4,921-4,780-7,129
Upgrade
Currency Exchange Gain (Loss)
-2,570-651.41329.73-149.04-150.86
Upgrade
Other Non Operating Income (Expenses)
15,864-1,251296.71-3,772-8,197
Upgrade
EBT Excluding Unusual Items
58,98933,88620,78918,56522,791
Upgrade
Gain (Loss) on Sale of Investments
46.49----
Upgrade
Gain (Loss) on Sale of Assets
4.9--1.71-4.14
Upgrade
Asset Writedown
-14.09-166.58-7.42-279.65-46.75
Upgrade
Other Unusual Items
--10.72---
Upgrade
Pretax Income
59,02733,70820,78218,28722,740
Upgrade
Income Tax Expense
15,0395,5645,8215,3735,440
Upgrade
Net Income
43,98828,14414,96112,91417,300
Upgrade
Net Income to Common
43,98828,14414,96112,91417,300
Upgrade
Net Income Growth
56.29%88.11%15.86%-25.36%-21.14%
Upgrade
Shares Outstanding (Basic)
1515151616
Upgrade
Shares Outstanding (Diluted)
1515151616
Upgrade
Shares Change (YoY)
0.01%-0.03%-0.61%-1.61%-
Upgrade
EPS (Basic)
2841.001818.00966.21828.841092.55
Upgrade
EPS (Diluted)
2841.001818.00966.00828.841092.55
Upgrade
EPS Growth
56.27%88.20%16.55%-24.14%-21.14%
Upgrade
Free Cash Flow
40,38329,4216,04911,18930,824
Upgrade
Free Cash Flow Per Share
2608.201900.50390.67718.131946.62
Upgrade
Dividend Per Share
--500.000500.000500.000
Upgrade
Gross Margin
25.83%25.31%25.38%28.87%32.30%
Upgrade
Operating Margin
16.12%14.92%14.34%16.73%21.50%
Upgrade
Profit Margin
19.77%13.61%7.92%7.60%9.43%
Upgrade
Free Cash Flow Margin
18.15%14.22%3.20%6.59%16.80%
Upgrade
EBITDA
51,59546,39342,04541,66151,697
Upgrade
EBITDA Margin
23.19%22.43%22.25%24.53%28.17%
Upgrade
D&A For EBITDA
15,73715,53114,95613,24512,246
Upgrade
EBIT
35,85830,86227,08928,41739,451
Upgrade
EBIT Margin
16.12%14.92%14.34%16.73%21.50%
Upgrade
Effective Tax Rate
25.48%16.51%28.01%29.38%23.92%
Upgrade
Advertising Expenses
1,5641,7311,6051,6661,039
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.